• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

44.23 +0.92 (+2.12%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,629,479
Open 43.61
Bid (Size) 44.27 (1)
Ask (Size) 44.34 (1)
Prev. Close 43.31
Today's Range 43.57 - 44.45
52wk Range 42.96 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.61%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bristol Myers (BMY) Q2 EPS Jumps 36%
August 01, 2025
Via The Motley Fool
Topics Intellectual Property
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
August 01, 2025
President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences. 
Via Benzinga
Topics Government

Performance

YTD
-22.1%
-22.1%
1 Month
-5.7%
-5.7%
3 Month
-11.6%
-11.6%
6 Month
-26.2%
-26.2%
1 Year
-9.3%
-9.3%

More News

Read More
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
July 31, 2025
Via Stocktwits
Topics Government
Bristol-Myers Squibb Unusual Options Activity For July 31
July 31, 2025
Via Benzinga
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
July 31, 2025
Via Benzinga
Topics Economy
Earnings Scheduled For July 31, 2025
July 31, 2025
Via Benzinga
Bristol-Myers Squibb Earnings Preview
July 30, 2025
Via Benzinga
Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today
July 31, 2025
Via StockStory
Topics Intellectual Property World Trade
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic
July 31, 2025
Via StockStory
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
July 31, 2025
Via Benzinga
Bristol-Myers Squibb Co (NYSE:BMY) Surpasses Q2 2025 Earnings and Revenue Estimates, Shares Rise in Pre-Market Trading
July 31, 2025
Via Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) – A High-Yield Dividend Stock with Strong Profitability and Financial Health
July 31, 2025
Via Chartmill
Bristol Myers Squibb Reports Second Quarter Financial Results for 2025
July 31, 2025
From Bristol Myers Squibb
Via Business Wire
Stock Market Today: S&P 500, Nasdaq To Open Higher After Robust Meta, Microsoft Earnings—Investors Await Apple, Amazon Results
July 31, 2025
Via Benzinga
Topics Stocks
Dow Falls Over 150 Points After Powell's Comments On Rate Cuts: Investor Sentiment Declines, But Fear Index Remains In 'Greed' Zone
July 31, 2025
Via Benzinga
Topics Economy Stocks
Microsoft, Apple And 3 Stocks To Watch Heading Into Thursday
July 31, 2025
Via Benzinga
Bristol Myers Squibb: A Stock with Potential Amid Challenges
July 30, 2025
Via The Motley Fool
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
July 30, 2025
Via The Motley Fool
Topics Intellectual Property
3 Low-Volatility Stocks We Find Risky
July 30, 2025
Via StockStory
Bristol-Myers Squibb (BMY) Q2 Earnings: What To Expect
July 29, 2025
Via StockStory
Topics Artificial Intelligence
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
July 28, 2025
From Bristol Myers Squibb
Via Business Wire
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
July 28, 2025
Via Benzinga
Biotech Is Booming, and This Undervalued REIT Stands to Gain
July 25, 2025
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session.
July 25, 2025
Via Chartmill
Cristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of Development
July 25, 2025
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 44.23
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 08/01/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 98.28B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 98B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap